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*Escherichia coli* strain 81009 was isolated from the urine of a 76-year-old male patient treated at Tawam Hospital, Al Ain, United Arab Emirates ([@B1]), and has recently been deposited at the Polish Collection of Microorganisms (PCM-2857). This strain belongs to sequence type 131 (ST131) and expresses the O25b O-antigen ([@B2]). *E. coli* 81009 is resistant to monobactams, cephalosporins, streptomycin, and fluoroquinolones and carries the *bla*~CTX-M-27~ allele. The recently emerging ST131-*H*30 isolates expressing CTX-M-27 are considered to form a new clade (C1-M27) within this clone ([@B3], [@B4]).

Genomic DNA of *E. coli* 81009 was extracted with the Genomic-tip 100/G kit and Genome buffer set (Qiagen) from bacteria grown in LB supplemented with 100 μg/ml ampicillin to mid-log phase (optical density at 600 nm \[OD~600~\], ∼0.5). The genomic material was sequenced on a PacBio RS II platform (Pacific Biosciences, USA) and with the Illumina HiSeq 2500 platform with a paired-end (PE) 125-bp read length (Illumina, The Netherlands).

Hierarchical Genome Assembly Process 4 (HGAP4) ([@B5]) was used for *de novo* assembly of the PacBio reads, and Illumina short reads were aligned to the *de novo* assembled genome with the Burrows-Wheeler Alignment tool (BWA) ([@B6]), followed by indel realignment and base quality recalibration with Genome Analysis Toolkit (GATK) ([@B7]). Protein-coding genes were called with Prodigal within the Prokka annotation pipeline ([@B8]). Trusted protein sequences for the annotation step were obtained from *E. coli* ST131 EC958 ([@B9]). Additional coding and noncoding RNA genes, as well as signal peptides, were predicted by RNAmmer, ARAGORN, SignalP, and Infernal within the Prokka annotation pipeline. The PlasmidFinder version 1.3 server ([@B10]) and ResFinder version 2.1 server ([@B11]) were used to identify plasmid *repA* genes and antibiotic resistance determinants.

*E. coli* 81009 has a circular chromosome of 5,012,084 bp and one plasmid (pEC-81009) with a length of 135,720 bp. The chromosome has a GC content of 50.8% and contains 4,987 predicted genes encoding 4,668 proteins and 319 RNAs (including 87 tRNAs, 22 rRNAs, and 1 transfer-messenger RNAs \[tmRNAs\]). A putative function was assigned to 91.7% of the protein-coding genes. The extraintestinal pathogen designation of *E. coli* 81009 was supported by an array of virulence determinants identified *in silico* ([@B12]), including those involved in adhesion (*upaB*, *crl*, *csgA*, *fimH*, and *iha*), biofilm formation (*bscA*, *agn43*, and F9 fimbriae), survival in body fluids (*iss* and *gad*), and toxin production (*senB* and *sat*). *E. coli* 81009 was also shown to carry the *H*30 allele of the *fimH* gene. Additionally, an 11.8-kb region (M27PP1) specific to the C1-M27 clade of the *H*30 subclone ([@B4]) was identified, confirming that strain 81009 belongs to the C1-M27 clade.

Plasmid pEC-81009 was found to belong to the IncFII-FIA-FIB group by *in silico* replicon typing ([@B10]). Among the 160 predicted genes carried on this plasmid, toxin/antitoxin systems (Phd/Doc, CcdBA, and Kid/Kis) and genes encoding resistance to aminoglycosides (*aadA5*, *strA*, and *strB*), sulfonamide (*sul1* and *sul2*), tetracycline \[*tet*(A)\], macrolides (*mphA*), trimethoprim (*dfrA17*), and the extended-spectrum β-lactamase (ESBL) gene *bla*~CTX-M-27~ were identified.

The availability of *E. coli* 81009 in a public repository and its well-characterized phenotype and genotype make it a suitable model organism for studying the ST131 C1-M27 clade.
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The complete sequences of the chromosome and plasmid of *E. coli* 81009 have been deposited in GenBank under accession numbers [CP021179](https://www.ncbi.nlm.nih.gov/nuccore/CP021179) and [CP021180](https://www.ncbi.nlm.nih.gov/nuccore/CP021180), respectively.
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